Trial
NCT03280342
Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Minnesota
Collaborators
Supernus Pharmaceuticals, Inc.
Condition
Migraine
Intervention
IR-TPM (Topamax)
Why stopped
Sponsor terminated study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-01